Drug Cost Management Report

View more issues:

Articles in Jan, 2003 issue of Drug Cost Management Report

• Shire Pharmaceuticals Group plc has delivered a supplemental New Drug Application to the FDA for marketing authorization for ADDERALL XR to treat attention deficit hyperactivity disorder in adults - sNDA - ADHD - Product News in Brief - Brief Article
• A framework for evaluating pharmacy cost management strategies in the public sector
  by Tim Watson
• Despite repeated safety warnings from the FDA, many Americans say they are likely to buy drugs from outside the U.S - Drug Cost Studies in Brief - Brief Article
• Paxil CR™ Controlled-Release Tablets can be used to safely and effectively treat older Americans suffering from depression - paroxetine HCl - Clinical News in Brief - Brief Article
• Employers can expect health care costs to continue to increase at a double-digit pace in 2003 - Drug Cost Studies in Brief - Brief Article
• Schering-Plough Corporation says that the U.S. launch of PEG-INTRON® Powder for Injection and REBETOL® Capsules combination therapy has been the most successful new product introduction in the company's history - peginterferon alfa-2b - ribavi
• Non-risk PPO market largely untapped by PBMs
• Sicker people who take more drugs are more likely to be noncompliant with recommended therapies - Drug Cost Studies in Brief - Brief Article
• Amgen announced results of a clinical study assessing 50 mg of ENBREL® dosed once weekly - etanercept - Clinical News in Brief - Brief Article
• A new study demonstrates that diuretics are more effective than newer, more expensive drugs in treating hypertension - Drug Cost Studies in Brief - Brief Article
• Novartis Pharmaceuticals Corporation has received the first-ever FDA approval for a drug to treat suicidal behavior - Product News in Brief - Brief Article
• Coming in February
• The top 10% of newly marketed drugs account for half of pharmaceutical industry's net returns - Drug Cost Studies in Brief - Brief Article
• Three out of four women currently taking prescriptions for osteoporosis are not receiving full treatment, according to recent data from a national physician audit - Clinical News in Brief - Brief Article
• States consider creating their own PBM
• Physicians serving the Medicaid population in Michigan and Vermont will now be able to access each state's Medicaid preferred drug list through their ePocrates Rx™ drug reference guide - Contracts and Alliances in Brief - Brief Article
• The Michigan Department of Community Health will proceed with enacting a plan of limiting doctors' prescribing practices for low-income patients - State News in Brief - Brief Article
• Aetna is taking steps to combat antibiotic resistance and inappropriate use of antibiotics - Drug Cost Strategies in Brief - Brief Article
• The Food and Drug Administration has taken action to restrict imports of certain prescription drugs - FDA - Product News in Brief - Brief Article
• Gary Mansfield has been appointed president and chief operating officer of the NMHCRX Mail Order, Inc - Company News in Brief - Brief Article
• PBMs' revenue sources, rebate accounting procedures explained
• The Walgreens drug store chain is now accepting the AARP MembeRx Choice and AARP Prescription Savings Service discount cards - Contracts and Alliances in Brief - Brief Article
• The Maryland Health Advocacy Alliance and the Monumental City Medical Society , are opposing a Medicaid preferred drug list proposed by the Maryland Department of Health and Mental Hygiene - MHAA - MCMS - DHMH - State News in Brief - Brief Article
• Employee cost-sharing up; trend to continue in 2003, study says
• Aetna's new Medicare offering, the Aetna Golden Choice™ Plan, becomes available this month to 1.3 million beneficiaries - Product News in Brief - Brief Article
• On Dec. 16, 2002, HealthExtras, Inc. , a pharmacy benefit management company serving over 2 million members, announced the acquisition of Pharmacy Network National Corporation of Raleigh, NC - Nasdaq: Hlex - PNNC - Company News in Brief - Brief Article